Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
Crossref DOI link: https://doi.org/10.1007/s00280-015-2683-1
Published Online: 2015-01-25
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Petrioli, Roberto
Roviello, Giandomenico
Fiaschi, Anna Ida
Laera, Letizia
Marrelli, Daniele
Roviello, Franco
Francini, Edoardo
Text and Data Mining valid from 2015-01-25